MENU
+Compare
VANI
Stock ticker: NASDAQ
AS OF
Nov 19, 04:59 PM (EDT)
Price
$1.35
Change
-$0.05 (-3.55%)
Capitalization
99.22M

VANI Vivani Medical Forecast, Technical & Fundamental Analysis

Vivani Medical Inc is a preclinical-stage biopharmaceutical company... Show more

VANI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VANI with price predictions
Nov 18, 2025

Aroon Indicator for VANI shows an upward move is likely

VANI's Aroon Indicator triggered a bullish signal on October 22, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 92 similar instances where the Aroon Indicator showed a similar pattern. In of the 92 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where VANI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VANI advanced for three days, in of 205 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VANI moved out of overbought territory on October 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VANI as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VANI turned negative on November 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

VANI moved below its 50-day moving average on November 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VANI crossed bearishly below the 50-day moving average on November 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VANI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VANI broke above its upper Bollinger Band on October 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VANI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (75.758) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (332.704).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VANI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VANI is expected to report earnings to fall 9.09% to -10 cents per share on March 26

Vivani Medical VANI Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Est.
$-0.11
The last earnings report on November 13 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 169.47K shares outstanding, the current market capitalization sits at 99.22M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1350 S. Loop Road
Phone
+1 415 506-8462
Employees
44
Web
https://www.vivani.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAJMF35.207.35
+26.39%
Kajima Corp.
DBIN38.98N/A
N/A
Dacotah Banks, Inc.
LIMAF54.86N/A
N/A
Linamar Corporation
MLLNF6.40N/A
N/A
Malin Corp PLC
OILCF3.61N/A
N/A
Permex Petroleum Corporation

VANI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
-4.76%
VTVT - VANI
60%
Loosely correlated
+0.23%
ADIL - VANI
37%
Loosely correlated
+0.10%
AXSM - VANI
36%
Loosely correlated
+1.28%
SCNI - VANI
34%
Loosely correlated
+1.10%
KYTX - VANI
28%
Poorly correlated
+9.50%
More